Anti-CD45RA antibody [SPM504]
- BOND RX™ Validated
- 20ul selling size
- Recombinant
- What is this?
4
(1 Review)
|
(2 Publications)
Mouse Recombinant Monoclonal CD45 antibody. Suitable for IHC-P and reacts with Human samples. Cited in 2 publications.
View Alternative Names
CD45, PTPRC, Receptor-type tyrosine-protein phosphatase C, Leukocyte common antigen, T200, L-CA
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD45RA antibody [SPM504] (AB231426)
Immunohistochemical analysis of paraffin-embedded human tonsil tissue labelling CD45RA with ab231426 at 1/200 dilution, followed by secondary antibody Goat Anti-Mouse IgG H&L (HRP polymer) (ab214879). Staining on human tonsil is observed. Counter stained with hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Mouse IgG H&L (HRP polymer) (ab214879).
The section was incubated with ab231426 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument.
Related conjugates and formulations (1)
-
Anti-CD45RA antibody [SPM504] - BSA and Azide free
Reactivity data
Product details
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CD45RA plays a significant role in regulating T-cell receptor (TCR) signaling. By dephosphorylating specific phosphotyrosine residues on substrates CD45RA modulates signal transduction pathways important for T-cell activation and differentiation. This protein does not act alone but is part of a regulatory network that influences immune responses and cellular development through its interaction with other cell surface receptors and intracellular kinases.
Pathways
CD45RA modulation is integral to T-cell development and activation processes. It is an important participant in the T-cell receptor signaling pathway and the Jak-STAT signaling pathway. In these pathways CD45 interacts with proteins such as Lck and Fyn which are essential for propagating receptor-mediated signaling events in T-cells. Effective signal regulation through CD45RA is necessary to ensure appropriate immune responses.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Experimental and therapeutic medicine 22:1180 PubMed34475970
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cellular & molecular immunology 17:380-394 PubMed31324882
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com